ELMARO DIN 02568527
Status: Approved
Holder: ELANCO CANADA LIMITED
Molecule: MAROPITANT (MAROPITANT CITRATE)
Available to quote
Health Canada record
| Active ingredient(s) | MAROPITANT (MAROPITANT CITRATE) 10 MG |
|---|---|
| Dosage form | Solution |
| Route | Subcutaneous; Intravenous |
| Schedule | PRESCRIPTION |
| Class | Veterinary |
| ATC | |
| Original market date | |
| Current status date | 27-May-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Elanco Canada Limited — licence 102236, currently licensed, last inspection rating C (2026-09-21).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MAROPITANT (MAROPITANT CITRATE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02299542 | CERENIA | ZOETIS CANADA INC | Solution | MAROPITANT (MAROPITANT CITRATE) 10 MG | Marketed |
| 02299526 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Marketed |
| 02299518 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Marketed |
| 02299496 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Marketed |
| 02299534 | CERENIA | ZOETIS CANADA INC | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Marketed |
| 02561360 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Marketed |
| 02561387 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Marketed |
| 02561395 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Marketed |
| 02561379 | EMAVERT TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Marketed |
| 02557908 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Approved |
| 02557894 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Approved |
| 02557916 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Approved |
| 02557924 | MAROFLIX TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Approved |
| 02561085 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 24 MG | Marketed |
| 02561107 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 160 MG | Marketed |
| 02561093 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 60 MG | Marketed |
| 02561077 | MAROPIKARE TABLETS | FELIX PHARMACEUTICALS PVT. LTD. | Tablet | MAROPITANT (MAROPITANT CITRATE) 16 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37608 | 2026-05-27 | Abbreviated New Drug Submission (ANDS) |